Patients with moderate to severe ulcerative colitis whose disease does not respond to oral glucocorticoids should be treated with either intravenous glucocorticoids or an anti–tumor necrosis factor agent.
If you want to change selection, open document below and click on "Move attachment"
- (no access) - MKSAP_17.pdf, p2740
|status||not read|| ||reprioritisations|
|last reprioritisation on|| ||suggested re-reading day|
|started reading on|| ||finished reading on|